Health Care & Life Sciences » Pharmaceuticals | Hubei Guangji Pharmaceutical Co. Ltd.

Hubei Guangji Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,956.00
229,592.90
18,415.70
145,316.90
106,055.40
173,409.90
Depreciation, Depletion & Amortization
66,947.20
68,264.30
54,644.70
73,318.00
82,874.60
83,039.30
Other Funds
26,383.30
3,750.70
31,070.50
35,518.70
94,675.70
20,393.90
Funds from Operations
61,799.70
43,608.20
138,844.50
266,498.90
236,036.80
238,942.30
Changes in Working Capital
33,823.40
30,639.90
171,840.30
99,114.10
56,968.60
66,115.10
Net Operating Cash Flow
95,623.20
74,248.10
32,995.80
167,384.80
179,068.20
172,827.20
Capital Expenditures
50,038.50
94,629.40
109,937.60
112,945.00
79,909.00
Sale of Fixed Assets & Businesses
9,801.10
1,169.10
23.50
1,350.70
-
Purchase/Sale of Investments
2,000.00
4,000.00
10,000.00
2,200.00
-
Net Investing Cash Flow
5,237.40
79,460.30
119,914.10
109,394.30
79,909.00
Issuance/Reduction of Debt, Net
94,375.70
237,485.00
145,993.50
60,349.20
26,880.30
Net Financing Cash Flow
120,759.00
241,235.70
114,923.00
95,867.90
67,795.40
Net Change in Cash
30,373.30
87,542.40
37,752.80
37,749.50
34,155.10
Free Cash Flow
45,584.70
168,877.50
142,933.40
54,439.90
99,159.20
Deferred Taxes & Investment Tax Credit
1,471.60
6,539.50
-
-
21,497.70
2,887
Other Sources
37,000.00
10,000.00
-
-
-
Exchange Rate Effect
-
15.10
234.20
127.90
2,791.30

About Hubei Guangji Pharmaceutical Co.

View Profile
Address
No. 1 Jiangdi Road
Wuxue Hubei 435400
China
Employees -
Website http://www.guangjipharm.com
Updated 07/08/2019
Hubei Guangji Pharmaceutical Co., Ltd. engages in the manufacture and sale pharmaceutical raw materials, and fine chemicals and preparation. It offers products in the form of granules, tablets, injections, ointments, and gels. Its products also include riboflavin vitamin B2 feed and pharmaceutical grade, lafutidine tablets, and tinidazole injections.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.